TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR- δ Upregulation
PPAR Research · 2014 · 2014 · 1-12
DOI: 10.1155/2014/491963 ↗Kurz gefasst
Fachartikel in der Zeitschrift PPAR Research, 2014. Verfasst von Feng Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension, Daping Hospital, T…. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: National Natural Science Foundation of China, National Basic Research Program of China.
Abstract (Originalsprache)
High-salt diet-induced cardiac hypertrophy and fibrosis are associated with increased reactive oxygen species production. Transient receptor potential vanilloid type 1 (TRPV1), a specific receptor for capsaicin, exerts a protective role in cardiac remodeling that resulted from myocardial infarction, and peroxisome proliferation-activated receptors δ (PPAR- δ ) play an important role in metabolic myocardium remodeling. However, it remains unknown whether activation of TRPV1 could alleviate cardiac hypertrophy and fibrosis and the effect of cross-talk between TRPV1 and PPAR- δ on suppressing high-salt diet-generated oxidative stress. In this study, high-salt diet-induced cardiac hypertrophy and fibrosis are characterized by significant enhancement of HW/BW%, LVEDD, and LVESD, decreased FS and EF, and increased collagen deposition. These alterations were associated with downregulation of PPAR- δ , UCP2 expression, upregulation of iNOS production, and increased oxidative/nitrotyrosine stress. These adverse effects of long-term high-salt diet were attenuated by chronic treatment with capsaicin. However, this effect of capsaicin was absent in TRPV1 −/− mice on a high-salt diet. Our finding suggests that chronic dietary capsaicin consumption attenuates long-term high-salt diet-induced cardiac hypertrophy and fibrosis. This benefit effect is likely to be caused by TRPV1 mediated upregulation of PPAR- δ expression.
Autor:innen und Institutionen
- Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
- Department of Ultrasound, Daping Hospital, Third Military Medical University, Chongqing 400042, China.
- Department of Cardiovascular Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.
Förderung
- National Natural Science Foundation of China
- National Basic Research Program of China
Zitieren
APA
Gao, F., Liang, Y., Wang, X., Lu, Z., Li, L., Zhu, S., Liu, D., Yan, Z., & Zhu, Z. (2014). TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR- δ Upregulation. PPAR Research, 2014, 1-12. https://doi.org/10.1155/2014/491963
Vancouver
Gao F, Liang Y, Wang X, Lu Z, Li L, Zhu S, et al. TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR- δ Upregulation. PPAR Research. 2014;2014:1-12. doi:10.1155/2014/491963
BibTeX
@article{Gao2014,
author = {Gao, Feng and Liang, Yi and Wang, Xiang and Lu, Zongshi and Li, Li and Zhu, Shanjun and Liu, Daoyan and Yan, Zhencheng and Zhu, Zhiming},
title = {TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR- δ Upregulation},
journal = {PPAR Research},
year = {2014},
volume = {2014},
pages = {1--12},
doi = {10.1155/2014/491963}
}
EUVIMED